We don't know that it hasn't. I suspect BASi is doing whatever small amount of initial testing the 200 g of Flucide that they got allows them to do.
We really don't know what the situation here is. It may be that multiple versions of Ebolacide2 are being made, so they can test them all and pick the one that works best. There isn't much point in speculating at this time.
Because Dr. Seymour didn't take my suggestion of cutting his own pay to $100,000 and applying the difference to a big offer to an outstanding chemist, rather than see the chemists go off to work for Wall Street.
Because, of course, everything is taking years longer than they expected the last time they said they had enough money to get through phase I/IIa. Wash, rinse, repeat.
How ugly? I'm thinking you said you represent a long who is unhappy with NNVC. Apologies if I have that wrong. Are the answers ugly enough that the investor you represent is getting out?